Diagnosing and grading gliomas using a proteomics approach
US7799519B2 · kind B2 · utility
4Cited by
0References
35Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 5, 2006 |
| Grant date | Sep 21, 2010 |
| Priority date | — |
| Expiry date | Jul 17, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/6848
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides for a proteomic approach to grading gliomas, and for predicting patient survival. In addition to employing global protein expression patterns, such as by mass spectrometry, particular target proteins whose expression is altered in various gliomas can be used to predict the stage/classification of a glioma, as well as to indicate whether a given patient will be a short- or long-term survivor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.